Shares of Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT – Get Free Report) have been given an average recommendation of “Buy” by the seven research firms that are presently covering the firm, Marketbeat Ratings reports. Seven research analysts have rated the stock with a buy recommendation. The average twelve-month price objective among brokers that have updated their coverage […]
Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT – Get Free Report)’s share price traded up 6.6% during trading on Wednesday . The stock traded as high as $9.96 and last traded at $9.91. 253,737 shares changed hands during mid-day trading, a decline of 77% from the average session volume of 1,124,942 shares. The stock had previously closed at […]
Shares of Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT – Free Report) have been assigned an average rating of “Buy” from the seven analysts that are covering the company, Marketbeat.com reports. Seven research analysts have rated the stock with a buy rating. The average 12 month price objective among brokers that have updated their coverage on the stock […]
Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT – Get Rating) has received a consensus recommendation of “Buy” from the seven analysts that are covering the firm, MarketBeat Ratings reports. Seven equities research analysts have rated the stock with a buy recommendation. The average 12-month price objective among analysts that have covered the stock in the last year is […]
Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT – Get Rating)’s stock price traded up 7.9% during mid-day trading on Tuesday . The stock traded as high as $11.28 and last traded at $11.02. 556,407 shares changed hands during trading, a decline of 48% from the average session volume of 1,077,242 shares. The stock had previously closed at $10.21. […]